Home/Filings/3/0001415889-24-030229
3//SEC Filing

NEXTECH CROSSOVER I SCSP 3

Accession 0001415889-24-030229

CIK 0001442836other

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 4:12 PM ET

Size

11.4 KB

Accession

0001415889-24-030229

Insider Transaction Report

Form 3
Period: 2024-12-20
Holdings
  • Common Stock

    12,067,246
Sgobbo Rocco
10% Owner
Holdings
  • Common Stock

    12,067,246
Holdings
  • Common Stock

    12,067,246
Charoub Ian
10% Owner
Holdings
  • Common Stock

    12,067,246
Holdings
  • Common Stock

    12,067,246
Footnotes (1)
  • [F1]The securities are held of record by Nextech Crossover I SCSp ("Nextech Crossover LP"). Nextech Crossover I GP S.a. r.l. ("Nextech Crossover GP") is the general partner of Nextech Crossover LP and Ian Charoub, Costas Constantinides and Rocco Sgobbo are Managers of Nextech Crossover GP. Nextech Crossover GP and Messrs. Charoub, Constantinides and Sgobbo may be deemed to share voting and investment power with respect to the securities reported herein and disclaim beneficial ownership over such securities, except to the extent of its or his respective pecuniary interest therein, if any.

Issuer

Mersana Therapeutics, Inc.

CIK 0001442836

Entity typeother
IncorporatedLuxembourg

Related Parties

1
  • filerCIK 0001894038

Filing Metadata

Form type
3
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 4:12 PM ET
Size
11.4 KB